U.S. markets open in 3 hours 46 minutes
  • S&P Futures

    3,836.75
    +8.75 (+0.23%)
     
  • Dow Futures

    31,379.00
    +8.00 (+0.03%)
     
  • Nasdaq Futures

    12,843.25
    +11.50 (+0.09%)
     
  • Russell 2000 Futures

    2,198.80
    -1.20 (-0.05%)
     
  • Crude Oil

    62.97
    -0.56 (-0.88%)
     
  • Gold

    1,764.10
    -11.30 (-0.64%)
     
  • Silver

    26.99
    -0.70 (-2.53%)
     
  • EUR/USD

    1.2130
    -0.0056 (-0.46%)
     
  • 10-Yr Bond

    1.5180
    0.0000 (0.00%)
     
  • Vix

    28.12
    +6.78 (+31.77%)
     
  • GBP/USD

    1.3918
    -0.0094 (-0.67%)
     
  • USD/JPY

    106.3600
    +0.1300 (+0.12%)
     
  • BTC-USD

    46,657.91
    -2,412.23 (-4.92%)
     
  • CMC Crypto 200

    932.51
    -0.63 (-0.07%)
     
  • FTSE 100

    6,620.36
    -31.60 (-0.48%)
     
  • Nikkei 225

    28,966.01
    -1,202.26 (-3.99%)
     

UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

SAN FRANCISCO, May 23, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate at the following healthcare conferences in June.

Jefferies 2019 Healthcare Conference

Date: June 6th, 2019
Time: 4:30 p.m. ET
Location: New York City, NY

Goldman Sachs 40th Annual Global Healthcare Conference

Date: June 11th, 2019
Time: 8:40 a.m. PT
Location: Rancho Palos Verdes, CA

A live audio webcast will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY

UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.

Investors
Endurance Advisors
Peter Rahmer
prahmer@enduranceadvisors.com

Media
Jason Spark
jason@canalecomm.com